Latest Tel Aviv Stock Exchange Stories
HAIFA, Israel, November 26, 2012 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (hereinafter "the Company," "ORL"), Israel's largest integrated refining and petrochemical group, announced that it has filed a shelf prospectus in Hebrew. This Prospectus will grant Oil Refineries flexibility in terms of time and scope of the capital raising, while enabling the Company to issue a broad variety of securities, as follows: - Up to 600 million Ordinary...
NETANYA, Israel, November 13, 2012 /PRNewswire/ -- ------------------------ Cellcom Israel presents a substantial improvement in free cash flow[1]for the third quarter, totaling NIS 414 million, a 58% increase in comparison to the third quarter last year Cellcom Israel continues the implementation of the efficiency plan and presents savings at an annual rate of...
MIGDAL HAEMEK, Israel, November 12, 2012 /PRNewswire/ -- Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) announced that it would be releasing its financial results for the third quarter of 2012 on Thursday, November 15, 2012. The company will also host a conference call on the same day, starting at 10:00 am ET. Roy Porat, Chief Executive Officer and Moshe Eisenberg, Chief Financial Officer, will host the call and will be available to answer questions after presenting the...
PETACH TIKVA, Israel, Nov. 5, 2012 /PRNewswire/ -- Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has received a FINRA quotation clearance of its Level 1 American Depository Receipts (ADRs). The ADRs are traded on the over-the-counter (OTC) market under the symbol CANFY. The Company's ordinary shares trade on the Tel Aviv Stock Exchange...
GIVAT SHMUEL, Israel, October 31, 2012 /PRNewswire/ -- Cimatron Limited (NASDAQ and TASE: CIMT), a leading provider of integrated CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts, announced today that it will be releasing its third quarter 2012 financial results on Wednesday, November 7th, 2012, before the US markets open. Cimatron's management will host a conference call that same day, at 9:00 EST, 16:00 Israel time....
ROCHELLE PARK, New Jersey, October 31, 2012 /PRNewswire/ -- Sapiens International Corporation [http://www.sapiens.com/home.html ], (NASDAQ and TASE: SPNS), a global provider of innovative software solutions for the financial services industries, today announced that it recently hosted its North American Client Conference on October 9-10 at the Hilton Times Square Hotel in midtown Manhattan. (Logo: http://photos.prnewswire.com/prnh/20120508/531104 ) The Client...
MIGDAL HAEMEK, Israel, October 29, 2012 /PRNewswire/ -- TowerJazz (NASDAQ: TSEM, TASE: TSEM), the global specialty foundry leader, will issue its third quarter 2012 earnings release on Thursday, November 15, 2012. The Company will hold a conference call to discuss its third quarter 2012 financial results and its fourth quarter and fiscal year 2012 guidance on Thursday, November 15, 2012, at 10:00 a.m. Eastern Time (09:00 a.m. Central, 08:00 a.m. Mountain, 07:00 a.m. Pacific...
MIGDAL HA'EMEK, Israel, October 23, 2012 /PRNewswire/ -- TowerJazz, the global specialty foundry leader, announced today that it received binding orders from Israeli institutional investors for approximately $25 million (approximately NIS95 million) through a private offering for the expansion of its existing Series F bonds, originally issued in 2010, maturing in two equal installments in December 2015 and December 2016. The newly issued Series F bonds will form a single...
ROCHELLE PARK, New Jersey, October 16, 2012 /PRNewswire/ -- Sapiens International Corporation [http://www.sapiens.com/home.html ], (NASDAQ and TASE: SPNS), a global provider of innovative insurance software solutions, announced today that The Trustmark Companies, based in Lake Forest, IL have selected Sapiens ALIS policy administration [http://www.sapiens.com/life-insurance-software.htm ] system to support Trustmark Voluntary Benefit business. Using Sapiens ALIS will enable...
HERZLIYA, Israel, October 4, 2012 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that following the announcement from September 24, 2012, its American Depositary Receipts ("ADRs") to ordinary shares ratio has changed today to 1:20 (1 ADR represents 20 ordinary shares). Please note that the ticker Symbol will temporarily change to XTLBD for 20 trading days beginning October 4th,...
